Vito Scalia

945 total citations
34 papers, 745 citations indexed

About

Vito Scalia is a scholar working on Epidemiology, Hepatology and Management of Technology and Innovation. According to data from OpenAlex, Vito Scalia has authored 34 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 13 papers in Hepatology and 12 papers in Management of Technology and Innovation. Recurrent topics in Vito Scalia's work include Hepatitis B Virus Studies (12 papers), Blood donation and transfusion practices (12 papers) and Hepatitis C virus research (11 papers). Vito Scalia is often cited by papers focused on Hepatitis B Virus Studies (12 papers), Blood donation and transfusion practices (12 papers) and Hepatitis C virus research (11 papers). Vito Scalia collaborates with scholars based in Canada, United States and Netherlands. Vito Scalia's co-authors include Sheila F. O’Brien, Qilong Yi, Wenli Fan, Margaret Fearon, Mindy Goldman, Eleftherios C. Vamvakas, Steven Kleinman, Douglas S. Palmer, Jean‐Pierre Allain and Graham D. Sher and has published in prestigious journals such as Journal of Clinical Microbiology, Transfusion and International Journal of Antimicrobial Agents.

In The Last Decade

Vito Scalia

34 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vito Scalia Canada 16 337 265 252 170 161 34 745
Francis Sarkodie United Kingdom 16 597 1.8× 531 2.0× 283 1.1× 59 0.3× 204 1.3× 23 979
Vanessa Piccinini Italy 14 145 0.4× 121 0.5× 120 0.5× 151 0.9× 135 0.8× 26 607
Nanci A. Salles Brazil 16 389 1.2× 148 0.6× 231 0.9× 53 0.3× 242 1.5× 42 718
M.P. Busch United States 17 542 1.6× 290 1.1× 265 1.1× 140 0.8× 371 2.3× 19 1.0k
Philip Kiely Australia 18 602 1.8× 401 1.5× 191 0.8× 71 0.4× 347 2.2× 46 972
Christoph Niederhauser Switzerland 15 314 0.9× 349 1.3× 79 0.3× 116 0.7× 367 2.3× 59 813
M. K. Hourfar Germany 18 333 1.0× 237 0.9× 150 0.6× 144 0.8× 329 2.0× 26 827
J. W. Mosley United States 15 295 0.9× 179 0.7× 99 0.4× 124 0.7× 385 2.4× 35 825
Peter L. Page United States 9 177 0.5× 43 0.2× 111 0.4× 93 0.5× 371 2.3× 13 748
Jaye P. Brodsky United States 10 170 0.5× 131 0.5× 70 0.3× 35 0.2× 186 1.2× 16 407

Countries citing papers authored by Vito Scalia

Since Specialization
Citations

This map shows the geographic impact of Vito Scalia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vito Scalia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vito Scalia more than expected).

Fields of papers citing papers by Vito Scalia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vito Scalia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vito Scalia. The network helps show where Vito Scalia may publish in the future.

Co-authorship network of co-authors of Vito Scalia

This figure shows the co-authorship network connecting the top 25 collaborators of Vito Scalia. A scholar is included among the top collaborators of Vito Scalia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vito Scalia. Vito Scalia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Delage, Gilles, Margaret Fearon, Yves Grégoire, et al.. (2019). Hepatitis E Virus Infection in Blood Donors and Risk to Patients in the United States and Canada. Transfusion Medicine Reviews. 33(3). 139–145. 22 indexed citations
2.
O’Brien, Sheila F., Qilong Yi, Wenli Fan, et al.. (2017). Residual risk of HIV, HCV and HBV in Canada. Transfusion and Apheresis Science. 56(3). 389–391. 28 indexed citations
3.
Fearon, Margaret, Sheila F. O’Brien, Gilles Delage, et al.. (2017). Hepatitis E in Canadian blood donors. Transfusion. 57(6). 1420–1425. 32 indexed citations
4.
Goldman, Mindy, et al.. (2016). Impact of informing donors of low ferritin results. Transfusion. 56(9). 2193–2198. 10 indexed citations
5.
Goldman, Mindy, et al.. (2016). A large national study of ferritin testing in Canadian blood donors. Transfusion. 57(3). 564–570. 48 indexed citations
6.
Fearon, Margaret, et al.. (2013). A Case of Vertical Transmission of Chagas Disease Contracted via Blood Transfusion in Canada. Canadian Journal of Infectious Diseases and Medical Microbiology. 24(1). 32–34. 19 indexed citations
8.
O’Brien, Sheila F., Qilong Yi, Wenli Fan, et al.. (2012). Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services. Vox Sanguinis. 103(1). 83–86. 56 indexed citations
9.
Palmer, Douglas S., et al.. (2010). Screening of Canadian Blood Services donors for severe immunoglobulin A deficiency. Transfusion. 50(7). 1524–1531. 23 indexed citations
10.
O’Brien, Sheila F., et al.. (2009). West Nile virus in 2006 and 2007: the Canadian Blood Services' experience. Transfusion. 50(5). 1118–1125. 13 indexed citations
11.
O’Brien, Sheila F., Guoliang Xi, Wenli Fan, et al.. (2008). Epidemiology of hepatitis B in Canadian blood donors. Transfusion. 48(11). 2323–2330. 29 indexed citations
12.
O’Brien, Sheila F., Jo Anne Chiavetta, Wenli Fan, et al.. (2008). Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing. Transfusion. 48(4). 755–761. 14 indexed citations
13.
O’Brien, Sheila F., Qilong Yi, Wenli Fan, et al.. (2007). Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services. Transfusion. 47(2). 316–325. 115 indexed citations
15.
Palmer, Douglas S., et al.. (2007). Flow cytometric determination of residual white blood cell levels in preserved samples from leukoreduced blood products. Transfusion. 48(1). 118–128. 20 indexed citations
16.
Larke, Bryce, et al.. (2002). Acute nosocomial HCV infection detected by NAT of a regular blood donor. Transfusion. 42(6). 759–765. 10 indexed citations
17.
Giulivi, Antonio, Robert Slinger, Martin Tepper, et al.. (2000). Prevalence of GBV-C/Hepatitis G Virus Viremia and Anti-E2 in Canadian Blood Donors. Vox Sanguinis. 79(4). 201–205. 11 indexed citations
20.
Nusbacher, Jacob, et al.. (1986). Evaluation of a confidential method of excluding blood donors exposed to human Immunodeficiency virus. Transfusion. 26(6). 539–541. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026